NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

寵物用醫藥品的全球市場:2020年∼2027年

Global Pet Medication Market - 2020-2027

出版商 DataM Intelligence 商品編碼 1004496
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
寵物用醫藥品的全球市場:2020年∼2027年 Global Pet Medication Market - 2020-2027
出版日期: 2021年05月10日內容資訊: 英文 180 Pages
簡介

“寵物用醫藥品”是有助於治療和預防疾病以及改善和延長家畜和伴侶動物壽命的產品類型,包括驅蟲劑、疫苗、抗感染藥和醫用飼料添加劑。創新和專業的優質產品、美容成本到藥品,寵物主人可支配收入的增加正在推動市場增長。

本報告提供全球寵物用醫藥品市場相關調查分析,提供產業分析,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 全球寵物用醫藥品市場調查手法與調查範圍

第2章 全球寵物用醫藥品市場:市場定義與市場概要

第3章 全球寵物用醫藥品市場:摘要整理

第4章 全球寵物用醫藥品市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球寵物用醫藥品市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求
  • 專利趨勢

第6章 全球寵物用醫藥品市場:COVID-19分析

  • COVID-19對市場的影響分析
  • 在COVID-19中的價格趨勢
  • 需求與供給的頻譜
  • 疫情期間與市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 全球寵物用醫藥品市場:各產品類型

  • 簡介
  • 產品類型各市場區隔的市場規模分析·與前一年同期比較成長率分析
  • 產品類型各市場區隔的市場魅力指數
    • 抗生素
    • 抗菌劑
    • 除蟲藥

第8章 全球寵物用醫藥品市場:各用途

  • 簡介
  • 各用途市場區隔的市場規模分析·與前一年同期比較成長率分析
  • 各用途市場區隔的市場魅力指數
    • 其他

第9章 全球寵物用醫藥品市場:各地區

  • 簡介
  • 各地區的市場規模分析·與前一年同期比較成長率分析
  • 各地區的市場魅力指數
  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第10章 全球寵物用醫藥品市場:競爭情形

  • 競爭模式
  • 市場定位/佔有率分析
  • 合併和收購分析

第11章 全球寵物用醫藥品市場:企業簡介

  • Zoetis
  • Merck
  • Merial
  • Boehringer
  • Novartis
  • Virbac
  • Ceva
  • Vetoquinol
  • Nexvet
  • Aratana Therapeutics
  • Kindred Biosciences
  • Ambrx
  • Entest Biomedical
  • Taconic Biosciences等

第12章 全球寵物用醫藥品市場:重要考察

第13章 全球寵物用醫藥品市場:MSG

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Overview

"Pet Medication" is the type of products that help treat and prevent diseases and improve and prolong the lives of farm animals and companion animals. These products include Parasiticides, vaccines, Anti-infective, medical feed additives, and others. The manufacturing and distribution of this drugs and medications are regulated under the United States federal agency for prescribing the veterinary animals. Veterinary prescription drugs are labeled for use only by or on the order of a licensed veterinarian, so it's necessary that these drugs must be properly labeled when dispensed. Also, the label should include all the information under the section on Basic Information for Records, Prescriptions, and Labels for the safety of pet animals. Factors such as rising pet owner's disposable income from innovative and specialized premium product and grooming expenses to medication drugs have augmenting the growth of the market. However, the rising incident of pet allergy, increasing prices of pet medications products and strict government regulations regarding pet ownership may hinder the growth of the market.

The global pet medication market size was worth US$ XX billion in 2019 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).

Market Dynamics

Veterinary diets includes animal foods that are specifically formed to aid in the management of disease and illness of a diagnosed health disorder in an animal. These veterinary diets are put together to treat a variety of problems in pets, such as digestive issues, itchy skin obesity, allergies, etc. Pet food manufacturers are constantly changing their product variants which makes them suitable for the wellness of pets, and thus, driving the growth of the market.

Increasing Trend of Smaller Families Driving Pet Adoption

Rapid urbanization in major developing countries across the globe has led to the increasing preference of couples to have smaller families. The increasing nature of the society, which results in the separation from farm animals and nature, is restoring the desire to bring pets home. Owing to company, social comfort, security, and the aesthetic sense offered by pets, the trend of pet adoption is increasing. Furthermore, high standard of living, high educational standards and , costly healthcare system have led to a decrease in the number of children and an increase in the adoption of pets, such as dogs, cats, and birds. This trend, in turn, is expected to increase the growth of the pet veterinary diet market in the long run.

Increasing Penetration Of Pet Insurance

The increasing penetration of pet insurance is anticipated to drive the animal medicine market. Worldwide, the pet insurance market is largely inactive with extremely less penetration rates providing a large market opportunity. Moreover, increasing penetration of pet insurance will increase the number of visits at veterinary clinics which will result in supporting the use of veterinary pharmaceuticals and feed additives in the treatment of different kind of diseases.

COVID-19 Impact Analysis

COVID-19 pandemic affected each and every country across the globe for instancethe direct impact on production and demand, supply chain disruption, and financial impact. Further, the sudded outbreak of this pandemic has disrupted the manufacturers' supply chain across the globe and shut down the production facilities to minimize the risk of virus spread. Due to which government imposed Social distancing and lockdowns across in most countries which directly or indirectly interrupted the production and supply of goods and raw materials in the pet medication market space. People are scared to go outside to get a checkup for their pets. This factor has led to major decline of the market. Transporation of such drugs is a major problem.

Segment Analysis

Based on the application, the pet medication market has been classified into dogs, cats, horse and others.

Dog segment dominated the global pet medication market in 2019

In 2019, the dog segment dominated the pet medication market owing to the high preference of dogs in the families.It is anticipated that canine segment will have a constant growth in market owing to highpreference by the families.Moreover, their cost of medication is also less.The rise in the number of dog owners and high spending on dogs care, coupled with high adoption rate of dogs for companionship and for security purpose is expected to further boost the demand for medications for canine care.The canine care medication market is followed by feline care medication market. Pet owners continue to rely on veterinarians for advice about pet medications: dog and cat owners important consideration when buying pet medications is medical advice from a veterinarian.

Based on the product type, the pet medication market has been classified into antibiotics, antimicrobial and antiparasitics.

Antiparastic drugs accounted for the highest market share in the global market

The antiparasitic drugs held the highest share in this segmentas this drugs helps to prevent, repel or kill internal or external parasites such as, intestinal protozoans (Giardia, etc.), intestinal wormsheartworms, fleas and ticks. Theantiparasitic drugs helps to cure various diseases. People prefers antiparastic due to itsproperties to protect the animals such as dogs, cats and others from diseases.

Geographical Analysis

Based on geography, the study analyzes the pet medication market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America leads the global market throughout the forecast period.

North America dominates the global pet medication market in terms of value and volume as the region is responsible for maximum number of pet food production worldwide, accompanied with the high demand for pet care, which result in driving the growth of the American pet medication market. The major distribution channels through which the US supplies pet diet are the pet superstores, mass retail stores, online sales, grocery chains, niche specialists, drugstores, and agricultural supply stores. Further, various research institute are focusing on pet medication in this region which is another factor for driving the growth of the market.

Competitive Landscape

The pet medication market is highly competitive, owing to the presence of big brands. The key market players are contributing to the growth of the global market include Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences

The major players are adopting new product launch and expansion strategies for global growth in the pet medication market.

Zoetis Inc.

Overview: Zoetis Inc. is an American drug company which is world's one of the largest producer of medicine and vaccinations for pets and livestock. Furthermore, the company was also a subsidiary of Virbac which is the world's one of the largest drug maker, but it is now a completely independent company. Moreover, the company directly markets the products in more than 40 countries, and also sells the products in more than 100 countries.

Product Portfolio: The company's product portfolio comprises pet food, medicines, farm animals, genetics and others.

Why Purchase the Report?

  • Visualize the pet medication market segmentation composition by product type, application, and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the pet medication market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of pet medication market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players.

The global pet medication market report would provide access to an approx. 60 market data table, 49 figures and 270 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Pet Medication Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Pet Medication Market - Market Definition and Overview

3. Global Pet Medication Market - Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Global Pet Medication Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing trend of smaller families driving pet adoption
      • 4.1.1.2. Increasing penetration of pet insurance
    • 4.1.2. Restraints:
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Pet Medication Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. Global Pet Medication Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Pet Medication Market - By Product Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  • 7.3. Market Attractiveness Index, By Product Type Segment
    • 7.3.1. Antibiotics*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Antimicrobial
    • 7.3.3. Antiparasitic

8. Global Pet Medication Market - By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Cats*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Dogs
    • 8.3.3. Horse
    • 8.3.4. Others

9. Global Pet Medication Market - By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Global Pet Medication Market - Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Global Pet Medication Market- Company Profiles

  • 11.1. Zoetis*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Merck
  • 11.3. Merial
  • 11.4. Boehringer
  • 11.5. Novartis
  • 11.6. Virbac
  • 11.7. Ceva
  • 11.8. Vetoquinol
  • 11.9. Nexvet
  • 11.10. Aratana Therapeutics
  • 11.11. Kindred Biosciences
  • 11.12. Ambrx
  • 11.13. Entest Biomedical
  • 11.14. Taconic Biosciences.

LIST NOT EXHAUSTIVE

12. Global Pet Medication Market - Premium Insights

13. Global Pet Medication Market - MSG

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us